Literature DB >> 14657503

RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.

A Ebralidze1, Y Wang, V Petkova, K Ebralidse, R P Junghans.   

Abstract

Myotonic dystrophy type 1 (DM1) is caused by a CUGn expansion (n approximately 50 to 5000) in the 3' untranslated region of the mRNA of the DM protein kinase gene. We show that mutant RNA binds and sequesters transcription factors (TFs), with up to 90% depletion of selected TFs from active chromatin. Diverse genes are consequently reduced in expression, including the ion transporter CIC-1, which has been implicated in myotonia. When TF specificity protein 1 (Sp1) was overexpressed in DM1-affected cells, low levels of messenger RNA for CIC-1 were restored to normal. Transcription factor leaching from chromatin by mutant RNA provides a potentially unifying pathomechanistic explanation for this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657503     DOI: 10.1126/science.1088679

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  57 in total

1.  Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons.

Authors:  Xianrong Mao; Shao-Hua Yang; James W Simpkins; Steven W Barger
Journal:  J Neurochem       Date:  2007-03       Impact factor: 5.372

2.  RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2.

Authors:  Karlie Jones; Bingwen Jin; Polina Iakova; Claudia Huichalaf; Partha Sarkar; Christiane Schneider-Gold; Benedikt Schoser; Giovanni Meola; Ann-Bin Shyu; Nikolai Timchenko; Lubov Timchenko
Journal:  Am J Pathol       Date:  2011-09-01       Impact factor: 4.307

3.  Spliceosomal genes in the D. discoideum genome: a comparison with those in H. sapiens, D. melanogaster, A. thaliana and S. cerevisiae.

Authors:  Bing Yu; Petra Fey; Karen E Kestin-Pilcher; Alexei Fedorov; Ashwin Prakash; Rex L Chisholm; Jane Y Wu
Journal:  Protein Cell       Date:  2011-06-12       Impact factor: 14.870

Review 4.  Myotonic dystrophy mouse models: towards rational therapy development.

Authors:  Mário Gomes-Pereira; Thomas A Cooper; Geneviève Gourdon
Journal:  Trends Mol Med       Date:  2011-07-02       Impact factor: 11.951

5.  In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models.

Authors:  Amparo García-López; Beatriz Llamusí; Mar Orzáez; Enrique Pérez-Payá; Ruben D Artero
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

6.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

Review 7.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

8.  FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.

Authors:  Karla L Bretherick; Margo R Fluker; Wendy P Robinson
Journal:  Hum Genet       Date:  2005-06-02       Impact factor: 4.132

9.  Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Authors:  Benedikt Schoser; Lubov Timchenko
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

10.  Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.

Authors:  Beatriz Llamusí; Ruben Artero
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.